Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 20/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17460471 | 0.99 | FFAR4 (0.83) | FFAR4 | |
| SCHEMBL17460606 | 0.93 | FFAR4 (0.76) | FFAR4 | |
| SCHEMBL17460625 | 0.90 | FFAR4 (1.00) | FFAR4 | |
| SCHEMBL17460572 | 0.90 | FFAR4 (1.00) | FFAR4 | |
| SCHEMBL17460615 | 0.89 | FFAR4 (0.84) | FFAR4 | |
| SCHEMBL17460603 | 0.89 | FFAR4 (0.66) | FFAR4 | |
| SCHEMBL17460602 | 0.88 | FFAR4 (0.66) | FFAR4 | |
| SCHEMBL17460636 | 0.86 | FFAR4 (0.82) | FFAR4 | |
| SCHEMBL17460490 | 0.85 | FFAR4 (0.89) | FFAR4 | |
| SCHEMBL17460622 | 0.85 | FFAR4 (0.80) | FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3172185-B1 | SUBSTITUTED PHENYL ALKANOIC ACID COMPOUNDS AS GPR120 AGONISTS AND USES THEREOF | PIRAMAL ENTPR LTD (IN) | 2020-03-04 | — | — | EP | disclosed |
| US-10273230-B2 | Substituted phenyl alkanoic acid compounds as GPR120 agonists and uses thereof | Piramal Enterprises Limited (IN) | 2019-04-30 | — | — | US | disclosed |
| US-20170210731-A1 | SUBSTITUTED PHENYL ALKANOIC ACID COMPOUNDS AS GPR120 AGONISTS AND USES THEREOF | Piramal Enterprises Limited (IN) | 2017-07-27 | — | — | US | disclosed |
| EP-3172185-A2 | SUBSTITUTED PHENYL ALKANOIC ACID COMPOUNDS AS GPR120 AGONISTS AND USES THEREOF | Piramal Enterprises Limited (IN) | 2017-05-31 | — | — | EP | disclosed |
| WO-2016012965-A2 | SUBSTITUTED PHENYL ALKANOIC ACID COMPOUNDS AS GPR120 AGONISTS AND USES THEREOF | Piramal Enterprises Limited (IN) | 2016-01-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170210731-A1 | SUBSTITUTED PHENYL ALKANOIC ACID COMPOUNDS AS GPR120 AGONISTS AND USES THEREOF | FFAR1, FFAR3, GPR55 | FFAR4 12/4885 |
| US-10273230-B2 | Substituted phenyl alkanoic acid compounds as GPR120 agonists and uses thereof | FFAR1, FFAR3, GPR55 | FFAR4 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.